Teva Pharmaceutical Industries Ltd
NYSE:TEVA
Revenue Breakdown
Breakdown by Geography
Teva Pharmaceutical Industries Ltd
Breakdown by Segments
Teva Pharmaceutical Industries Ltd
Total Revenue:
15.8B
USD
|
Product:
12.8B
USD
|
North America Segment:
7.5B
USD
|
Europe Segment:
4.5B
USD
|
International Markets:
1.9B
USD
|
Generics Medicians:
1.6B
USD
|
Distribution Service:
1.5B
USD
|
Anda:
1.5B
USD
|
Other Activities:
1B
USD
|
Austedo:
963m
USD
|
Product And Service, Other:
428m
USD
|
Bendeka And Treanda:
316m
USD
|
Respiratory Product:
273m
USD
|
Other Products:
246m
USD
|
License:
212m
USD
|
Copaxone:
36m
USD
|
Ajovy:
35m
USD
|